Short-Course Systemic and Topical Non-Steroidal Anti-Inflammatory Drugs: Impact on Adverse Renal Events in Older Adults with Co-Morbid Disease
- 30 November 2020
- journal article
- research article
- Published by Springer Nature in Drugs & Aging
- Vol. 38 (2) , 147-156
Abstract
Background Prolonged systemic non-steroidal anti-inflammatory drugs (NSAIDs) have been associated with adverse renal outcomes among older adults. However, there is scant data regarding the renal safety of topical and short-course systemic NSAIDs. We aimed to evaluate the risk of acute adverse renal outcomes among older adults prescribed topical and short-term systemic NSAIDs. Methods We conducted a retrospective cohort study of all older adults, age 60 years and above, who received prescriptions between July 2015 and December 2017 from the largest tertiary hospital and a major public primary care institution in Singapore. Data from 6 months before until 30 days after the first prescription were retrieved from electronic medical records. The primary outcome was the incidence of acute kidney injury (serum creatinine increased >26.5 µmol/L or >50% from baseline) and/or hyperkalemia within 30 days. A multi-variate analysis taking into account age, sex, co-morbidities, baseline-estimated glomerular filtration rate and serum potassium, NSAID route of administration, and concurrent renin-angiotensin-aldosterone system blocker and diuretic prescription was performed to evaluate factors associated with the primary outcome. Results We identified 12,773 older adults with incident prescriptions: 3982 (31.2%) received short-course systemic NSAIDs, 3784 (29.6%) received topical NSAIDs, and 5007 (39.2%) did not receive any NSAID. Both short-course systemic NSAIDs (adjusted odds ratio [OR] 1.59, 95% confidence interval [CI] 1.41–1.80, p < 0.001) and topical NSAIDs (adjusted OR 1.48, 95% CI 1.31–1.67, p < 0.001), compared with the no-NSAID group, were independently associated with the primary outcome. Among older adults with co-morbid conditions and prescribed NSAIDs, topical NSAIDs had a reduced odds of 30-day incident acute kidney injury and/or hyperkalemia in diabetes mellitus (adjusted OR 0.78, 95% CI 0.65–1.06, p = 0.007), chronic kidney disease (adjusted OR 0.74, 95% CI 0.60–0.90, p = 0.003), and cardiovascular disease (adjusted OR 0.54, 95% CI 0.37–0.79, p < 0.001), compared with short-course systemic NSAIDs. Conclusions NSAIDs increased the risk of acute adverse renal events. Topical NSAIDs, compared with short-course systemic NSAIDs, were associated with a reduced incidence of acute kidney injury and/or hyperkalemia among older adults with additional risk factors.Keywords
Funding Information
- SHF-Foundation Research Grant (SHF/HSRHO014/2017)
This publication has 33 references indexed in Scilit:
- Non-steroidal anti-inflammatory drug (NSAID) therapy in patients with hypertension, cardiovascular, renal or gastrointestinal comorbidities: joint APAGE/APLAR/APSDE/APSH/APSN/PoA recommendationsGut, 2020
- Nonsteroidal anti-inflammatory drug use and risk of acute kidney injury and hyperkalemia in older adults: a population-based studyNephrology Dialysis Transplantation, 2019
- American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older AdultsJournal of the American Geriatrics Society, 2019
- Relative efficacy and safety of topical non-steroidal anti-inflammatory drugs for osteoarthritis: a systematic review and network meta-analysis of randomised controlled trials and observational studiesBritish Journal of Sports Medicine, 2018
- Risk of acute myocardial infarction with real‐world NSAIDs depends on dose and timing of exposurePharmacoepidemiology and Drug Safety, 2017
- Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: systematic review and meta-analysisBMC Nephrology, 2017
- New guidelines for topical NSAIDs in the osteoarthritis treatment paradigmCurrent Medical Research and Opinion, 2010
- Cyclooxygenase Inhibition Causes Marked Impairment of Renal Function in Elderly Subjects Treated with Diuretics and ACE-InhibitorsEuropean Journal of Heart Failure, 2005
- Oral versus Topical NSAIDs in Rheumatic DiseasesDrugs, 2000
- Consumption of NSAIDs and the Development of Congestive Heart Failure in Elderly PatientsArchives of internal medicine (1960), 2000